Next, we explored RUNX2 expression in NPC tissue; our IHC data showed that RUNX2 expression levels were significantly increased in tumor tissues (Fig. 5E), which were further confirmed using the TCGA database (Fig. 5F). Here, RUNX2 is linked to nasopharyngeal carcinoma.